INmune Bio (INMB)
Develops innate-immunity therapies for rare disease, Alzheimer’s disease and cancer.
$2.43
Pre-market+0.07 (+2.97%)
At close$2.36(+5.36%)
Something off on this page? Send us feedback.
Next report
Oct 29, 2026
in 56 days
EPS estimate
−$0.15
Revenue estimate
$1.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Oct '25Mar '26May '26Aug '26Oct '26
Reported−$0.40−$0.43−$0.34−$0.24−$0.18−$0.20−$0.05Pending
Estimate−$0.54−$0.43−$0.37−$0.31−$0.27−$0.25−$0.21−$0.15
Surprise+25.9%0.0%+8.1%+22.6%+33.3%+18.4%+75.8%—
RevenueReportedEstimate
Mar '25May '25Aug '25Oct '25Mar '26May '26Aug '26Oct '26
Reported—$50.0K—————Pending
Estimate————−$6.1K$1.1M$1.2M$1.9M
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | −$0.15 | — | — |
| Aug 2026 | −$0.21 | −$0.05 | +75.8% |
| May 2026 | −$0.25 | −$0.20 | +18.4% |
| Mar 2026 | −$0.27 | −$0.18 | +33.3% |
| Oct 2025 | −$0.31 | −$0.24 | +22.6% |
The latest year is open to everyone — the 36 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | −$0.15 | — | — | $1.9M | — | — | — |
| Aug 6, 2026 | −$0.21 | −$0.05 | +75.8% | $1.2M | — | — | +9.4% |
| May 7, 2026 | −$0.25 | −$0.20 | +18.4% | $1.1M | — | — | 0.0% |
| Mar 30, 2026 | −$0.27 | −$0.18 | +33.3% | −$6.1K | — | — | −0.9% |
| Oct 30, 2025 | −$0.31 | −$0.24 | +22.6% | — | — | — | +5.8% |
The latest year is open to everyone — the 36 quarters behind it read with an account. Sign in | |||||||
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Oct 31, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Nov 1, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 3, 2023 | |||||||
| Mar 2, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 5, 2022 | |||||||
| Mar 3, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 4, 2021 | |||||||
| May 5, 2021 | |||||||
| Mar 4, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 11, 2020 | |||||||
| Nov 8, 2019 | |||||||
| Aug 9, 2019 | |||||||
| May 15, 2019 | |||||||
| Mar 29, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||